Cumberland Pharmaceuticals (CPIX) Consolidated Net Income (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Consolidated Net Income across 16 years of filings, most recently posting -$3.1 million for Q1 2026.

• Consolidated Net Income for Q1 2026 came in at -$3.1 million, down 351.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.2 million (down 119.87% YoY), and the FY2025 annual result was -$2.9 million, up 55.75% from the prior year.
• Consolidated Net Income came in at -$3.1 million for Q1 2026 at Cumberland Pharmaceuticals, down from -$1.4 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $1.2 million in Q1 2025 to a low of -$6.3 million in Q4 2023.
• The 4-year median for Consolidated Net Income is -$1.4 million (2025), against an average of -$1.4 million.
• Across the five-year window, Consolidated Net Income plunged 1204.25% in 2024 and soared 165.61% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Consolidated Net Income stood at -$6.3 million in 2023, then jumped by 69.82% to -$1.9 million in 2024, then increased by 25.58% to -$1.4 million in 2025, then tumbled by 121.95% to -$3.1 million in 2026.
• The last three Consolidated Net Income figures came in at -$3.1 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.